Lonza AG
Records under this name other than the patents Lonza AG holds now: patents now held by others, patents whose terms have ended, and its applications, pending or abandoned. None of them is counted in the 11 patents it holds.
| Patent | Title | Status | Expires | Confidence |
|---|---|---|---|---|
| US 9,040,480 | Synthesis of glucagon-like peptide Formerly held In force · From the USPTO record | In force | From the USPTO record | |
| US 7,939,698 | Method for grignard type reactions in microreactors Formerly held In force · From the USPTO record | In force | From the USPTO record | |
| US 10,865,416 | Recombinant Host Cell Engineered to Overexpress Helper Proteins Formerly held In force · High confidence | In force | High confidence | |
| US 10,590,427 | Recombinant Host Cell for Expressing Proteins of Interest Formerly held In force · High confidence | In force | High confidence | |
| US 11,713,297 | Crystalline Form of N-Butyldeoxygalactonojirimycin Formerly held In force · High confidence | In force | High confidence | |
| US 11,306,058 | Crystalline Form of N-Butyldeoxygalactonojirimycin Formerly held In force · High confidence | In force | High confidence | |
| US 11,530,175 | Method for Preparation of Fluoro Alkylated Compounds by Homogeneous NI Catalysis Formerly held In force · High confidence | In force | High confidence | |
| US 12,497,447 | ANTI-GDF15 Antibody and a Dosage Regimen for the Treatment of Cancer Formerly held In force · High confidence | In force | High confidence | |
| US D664,262 | Impeller arrangement for fermenter Formerly held Term ended Term ended Jul 24, 2026 · From the USPTO record | Term ended | Term ended Jul 24, 2026 | From the USPTO record |
| US 11,332,456 | Method for Preparation of Fluoro Alkylated 1,4-Dioxene by Homogeneous NI Catallysis Formerly held Lapsed on the fee record Ended May 17, 2026 · High confidence | Lapsed on the fee record | Ended May 17, 2026 | High confidence |